Whitepaper Download
Annex 22 & AI in the lab
The new EU GMP draft Annex 22 is causing uncertainty in the pharmaceutical industry: what role can artificial intelligence play in the laboratory in future - and where are the limits? This white paper provides a clear guide for laboratory managers, quality managers and digitalization experts.
It explains how Annex 22 differentiates between "critical" and "non-critical" applications, shows practical examples from everyday laboratory work and provides specific recommendations for the compliant use of AI. You will also learn how specialized systems such as Thunder AI can help laboratories to work more efficiently and at the same time in compliance with GxP - without the risk of validation.
This white paper is available in German and English.





















.jpg)
.jpg)

